诱导多能干细胞衍生间充质干细胞疗法的研究进展及创新策略（二）

[1] K. Takahashi, S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell 126(4) (2006) 663-76.

[2] K. Kim, R. Zhao, A. Doi, K. Ng, J. Unternaehrer, P. Cahan, H. Huo, Y.H. Loh, M.J. Aryee, M.W. Lensch, H. Li, J.J. Collins, A.P. Feinberg, G.Q. Daley, Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells, Nat Biotechnol 29(12) (2011) 1117-9.

[3] Y. Ohi, H. Qin, C. Hong, L. Blouin, J.M. Polo, T. Guo, Z. Qi, S.L. Downey, P.D. Manos, D.J. Rossi, J. Yu, M. Hebrok, K. Hochedlinger, J.F. Costello, J.S. Song, M. Ramalho-Santos, Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells, Nat Cell Biol 13(5) (2011) 541-9.

[4] O. Bar-Nur, H.A. Russ, S. Efrat, N. Benvenisty, Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells, Cell Stem Cell 9(1) (2011) 17-23.

[5] K. Hynes, D. Menicanin, K. Mrozik, S. Gronthos, P.M. Bartold, Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines, Stem Cells Dev 23(10) (2014) 1084-96.

[6] Q. Lian, Y. Zhang, J. Zhang, H.K. Zhang, X. Wu, Y. Zhang, F.F. Lam, S. Kang, J.C. Xia, W.H. Lai, K.W. Au, Y.Y. Chow, C.W. Siu, C.N. Lee, H.F. Tse, Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice, Circulation 121(9) (2010) 1113-23.

[7] M. Giuliani, N. Oudrhiri, Z.M. Noman, A. Vernochet, S. Chouaib, B. Azzarone, A. Durrbach, A. Bennaceur-Griscelli, Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery, Blood 118(12) (2011) 3254-62.

[8] H. Wei, G. Tan, Manasi, S. Qiu, G. Kong, P. Yong, C. Koh, T.H. Ooi, S.Y. Lim, P. Wong, S.U. Gan, W. Shim, One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells, Stem Cell Res 9(2) (2012) 87-100.

[9] W.X. Gao, Y.Q. Sun, J. Shi, C.L. Li, S.B. Fang, D. Wang, X.Q. Deng, W. Wen, Q.L. Fu, Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells, Stem Cell Res Ther 8(1) (2017) 48.

[10] Q. Zhao, C.A. Gregory, R.H. Lee, R.L. Reger, L. Qin, B. Hai, M.S. Park, N. Yoon, B. Clough, E. McNeill, D.J. Prockop, F. Liu, MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs, Proc Natl Acad Sci U S A 112(2) (2015) 530-5.

[11]T. Später, G. Kaneda, M. Chavez, J. Sheyn, J. Wechsler, V. Yu, P. Del Rio, D. Huang, M. Metzger, W. Tawackoli, D. Sheyn, Retention of Human iPSC-Derived or Primary Cells Following Xenotransplantation into Rat Immune-Privileged Sites, Bioengineering (Basel) 10(9) (2023).

[12] S. Mitsuzawa, R. Ikeguchi, T. Aoyama, M. Ando, H. Takeuchi, H. Yurie, H. Oda, T. Noguchi, S. Ohta, C. Zhao, M. Ikeya, S. Matsuda, Induced pluripotent stem cell-derived mesenchymal stem cells prolong hind limb survival in a rat vascularized composite allotransplantation model, Microsurgery 39(8) (2019) 737-747.

[13] H. Yang, R. Feng, Q. Fu, S. Xu, X. Hao, Y. Qiu, T. Feng, Z. Zeng, M. Chen, S. Zhang, Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models, Cell Death Dis 10(10) (2019) 718.

[14] P. Jungbluth, L.S. Spitzhorn, J. Grassmann, S. Tanner, D. Latz, M.S. Rahman, M. Bohndorf, W. Wruck, M. Sager, V. Grotheer, P. Kröpil, M. Hakimi, J. Windolf, J. Schneppendahl, J. Adjaye, Human iPSC-derived iMSCs improve bone regeneration in mini-pigs, Bone Res 7 (2019) 32.

[15] M. Zhou, J. Xi, Y. Cheng, D. Sun, P. Shu, S. Chi, S. Tian, S. Ye, Reprogrammed mesenchymal stem cells derived from iPSCs promote bone repair in steroid-associated osteonecrosis of the femoral head, Stem Cell Res Ther 12(1) (2021) 175.

[16] K. Hynes, D. Menicanin, J. Han, V. Marino, K. Mrozik, S. Gronthos, P.M. Bartold, Mesenchymal stem cells from iPS cells facilitate periodontal regeneration, J Dent Res 92(9) (2013) 833-9.

[17] A. Lo Cicero, A.L. Jaskowiak, A.L. Egesipe, J. Tournois, B. Brinon, P.R. Pitrez, L. Ferreira, A. de Sandre-Giovannoli, N. Levy, X. Nissan, A High Throughput Phenotypic Screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells, Sci Rep 6 (2016) 34798.

[18]M. Arakawa, Y. Sakamoto, Y. Miyagawa, C. Nito, S. Takahashi, Y. Nitahara-Kasahara, S. Suda, Y. Yamazaki, M. Sakai, K. Kimura, T. Okada, iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress, Mol Ther Methods Clin Dev 30 (2023) 333-349.

[19] S.W. Lim, K.W. Kim, B.M. Kim, Y.J. Shin, K. Luo, Y. Quan, S. Cui, E.J. Ko, B.H. Chung, C.W. Yang, Alleviation of renal ischemia/reperfusion injury by exosomes from induced pluripotent stem cell-derived mesenchymal stem cells, Korean J Intern Med 37(2) (2022) 411-424.

[20] Q. Miao, W. Shim, N. Tee, S.Y. Lim, Y.Y. Chung, K.P. Ja, T.H. Ooi, G. Tan, G. Kong, H. Wei, C.H. Lim, Y.K. Sin, P. Wong, iPSC-derived human mesenchymal stem cells improve myocardial strain of infarcted myocardium, J Cell Mol Med 18(8) (2014) 1644-54.

[21] Y. Liang, X. Li, Y. Zhang, S.C. Yeung, Z. Zhen, M.S.M. Ip, H.F. Tse, Q. Lian, J.C.W. Mak, Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells Attenuate Cigarette Smoke-Induced Cardiac Remodeling and Dysfunction, Front Pharmacol 8 (2017) 501.

[22] Z. Chen, X. Han, X. Ouyang, J. Fang, X. Huang, H. Wei, Transplantation of induced pluripotent stem cell-derived mesenchymal stem cells improved erectile dysfunction induced by cavernous nerve injury, Theranostics 9(22) (2019) 6354-6368.

[23] A.J.C. Bloor, A. Patel, J.E. Griffin, M.H. Gilleece, R. Radia, D.T. Yeung, D. Drier, L.S. Larson, G.I. Uenishi, D. Hei, K. Kelly, I. Slukvin, J.E.J. Rasko, Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study, Nat Med 26(11) (2020) 1720-1725.

[24] G. Xie, H. Dong, Y. Liang, J.D. Ham, R. Rizwan, J. Chen, CAR-NK cells: A promising cellular immunotherapy for cancer, EBioMedicine 59 (2020) 102975.

[25]A.J.C. Bloor, A. Patel, J.E. Griffin, M.H. Gilleece, R. Radia, D.T. Yeung, D. Drier, L.S. Larson, G.I. Uenishi, D. Hei, K. Kelly, I. Slukvin, J.E.J. Rasko, Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study, Nat Med 26(11) (2020) 1720-1725.